LP-PLA2与冠状动脉粥样硬化性心脏病的研究进展

被引:3
作者
陈锦峰
徐新
机构
[1] 汕头大学医学院附属粤北人民医院心内科
关键词
脂蛋白相关磷脂酶A2; 冠状动脉粥样硬化; 冠状动脉疾病;
D O I
10.13191/j.chj.2010.03.138.chenjf.029
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
近年研究发现,脂蛋白相关磷脂酶A2(Lp-PLA2)是不同于白细胞介素、细胞间黏附分子和高敏C反应蛋白(hs-CRP)等传统冠心病危险因子,成为冠心病新的预测因子,并指出其与动脉粥样硬化性病变及斑块稳定密切相关。
引用
收藏
页码:444 / 446
页数:3
相关论文
共 8 条
[1]   炎症标记物与冠心病关系的研究进展 [J].
李巧汶 ;
邱健 .
心脏杂志, 2008, (03) :359-362
[2]   脂蛋白相关磷脂酶A2与动脉粥样硬化性疾病 [J].
朱毓 ;
吴美华 .
心脏杂志, 2008, (01) :101-103
[3]  
Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial[J] . Michelle O’Donoghue,David A. Morrow,Marc S. Sabatine,Sabina A. Murphy,Carolyn H. McCabe,Christopher P. Cannon,Eugene Braunwald.Circulation . 2006 (14)
[4]  
Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J] . Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Circulation . 2005 (5)
[5]  
CLINICAL REVIEW: Lipoprotein-Associated Phospholipase A2, a Novel Inflammatory Biomarker and Independent Risk Predictor for Cardiovascular Disease[J] . Krishnankutty Sudhir.The Journal of Clinical Endocrinology & Metabolism . 2005 (5)
[6]  
Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors: The Ludwigshafen Risk and Cardiovascular Health Study[J] . Circulation . 2005 (8)
[7]  
Lipoprotein-associatedphospholipase A2 protein expression in the natural progression ofhuman coronary atherosclerosis. Kolodgie FD,Burke AP,Skorija KS,et al. Arteriosclerosis and Thrombosis . 2006
[8]  
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors,markers of inflammation,renal function,and hemodynamic stress. Koenig W,Twardella D,Brenner H,et al. Arteriosclerosis and Thrombosis . 2006